Skip to main content
21+Industry intelligence — not direct nicotine sales

Archive

All articles

2772 published stories · page 1 of 185. Editor summaries with links to original reporting — see Editorial analysis for original commentary, or Latest on the hub.

Regulation & Policy

Safety Public Assessment Reports

These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.

Regulation & PolicyOct 15, 2026UK MHRA (Atom)
Science & Policy

Research: Antidepressants – updated safety communications

Public Assessment Report on the review of antidepressants. How the risks of suicidal thoughts and behaviours and sexual dysfunction (where symptoms continue after stopping treatment), are communicated to patients.

Science & PolicyOct 15, 2026UK MHRA (Atom)
Regulation & Policy

Guidance: Antidepressants: use and safety

Guidance on the use and side effects of selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs), their safety, use in pregnancy and the risk of suicidal behaviour.

Regulation & PolicyOct 15, 2026UK MHRA (Atom)